Selection of goat β-casein derived ACE-inhibitory peptide SQPK and insights into its effect and regulatory mechanism on the function of endothelial cells

Yulong Wu,Jin Zhang,Tong Mu,Hong Zhang,Jianxin Cao,Huanhuan Li,Honggang Tang,Lihong Chen,Hongyun Liu,Xianrong Xu,Ke Zhao
DOI: https://doi.org/10.1016/j.ijbiomac.2023.127312
IF: 8.2
2023-10-18
International Journal of Biological Macromolecules
Abstract:The angiotensin I-converting enzyme (ACE)-inhibitory peptide SQPK was selected by in silico digestion and virtual screening from goat β-casein, and its effect and regulatory mechanism on function of endothelial cells was further evaluated. The results showed that SQPK exhibited relatively good ACE inhibition capacity (IC 50 = 452.7 μg/mL). Treatment with 25 μg/mL SQPK for 12 h significantly elevated nitric oxide (NO) production, stimulated eNOS expression ( p < 0.05) and affected the transcriptomic profiling of EA. Hy926 cells. In particular, SQPK stimulated the expression of genes encoding inflammatory cytokines ( CXCL1/2 and IL6 ) but depressed encoding mesenchymal markers ( FN1 and CNN3 ). Furthermore, SQPK modified the expression of genes involved in endothelial-to-mesenchymal transition (EndMT). Therefore, the selected peptide SQPK may exert potential protective effects on the function of endothelial cells by inhibiting the EndMT.
polymer science,biochemistry & molecular biology,chemistry, applied
What problem does this paper attempt to address?